Indeed, a better understanding of the anti-inflammatory nature of estrogen receptors and their role in regulating the expression of inflammation-related molecules by breast cancer cells may help us identify novel molecular targets and personalized therapeutic options. The gene discussed is ESR1; the disease is breast cancer.